About WuXi AppTec
WuXi AppTec is a company based in Shanghai (China) founded in 2000.. WuXi AppTec has raised $40 million across 5 funding rounds from investors including General Atlantic, Warburg Pincus and Eight Roads Ventures. The company has 1,681 employees as of December 31, 2022. WuXi AppTec has completed 10 acquisitions, including Abgent, Ambrx and Crelux. WuXi AppTec operates in a competitive market with competitors including Eurofins Scientific, Ipsen, ANI Pharmaceuticals, Red Nucleus and Aptar, among others.
- Headquarter Shanghai, China
- Employees 1681 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$8.27 M (USD)-3as on Dec 31, 2023
-
Net Profit
$-9.82 M (USD)48as on Dec 31, 2023
-
EBITDA
-
Total Equity Funding
$40 M (USD)
in 5 rounds
-
Latest Funding Round
$15.88 M (USD), Post-IPO
Apr 02, 2021
-
Investors
General Atlantic
& 4 more
-
Employee Count
1681
as on Dec 31, 2022
-
Investments & Acquisitions
Abgent
& 9 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Leadership Team
25 people
Software Development Team
25 people
Sales and Marketing
15 people
Human Resources and Administration
15 people
Operations Team
7 people
Senior Team
5 people
Legal and Compliance
4 people
Creative and Marketing Team
3 people
Unlock access to complete
Funding Insights of WuXi AppTec
WuXi AppTec has successfully raised a total of $40M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $15.88 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $15.9M
-
First Round
First Round
(01 Feb 2007)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2021 | Amount | Post-IPO - WuXi AppTec | Valuation |
investors |
|
| Aug, 2020 | Amount | Post-IPO - WuXi AppTec | Valuation |
investors |
|
| Mar, 2016 | Amount | Debt – Conventional - WuXi AppTec | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in WuXi AppTec
WuXi AppTec has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include General Atlantic, Warburg Pincus and Eight Roads Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage private equity investments are pursued across diverse sectors.
|
Founded Year | Domain | Location | |
|
Venture capital investment and global platform support for startups.
|
Founded Year | Domain | Location | |
|
Private equity fund focused on global markets
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by WuXi AppTec
WuXi AppTec has strategically engaged in corporate development activities, having acquired 10 companies. Notable acquisitions include Abgent, Ambrx and Crelux. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drug quality control solutions are provided for pharmaceuticals.
|
2018 | ||||
|
Genomics platform for clinical insights and rapid diagnoses is provided.
|
2013 | ||||
|
Integrated silicon photonics products are developed for optical communication applications.
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - WuXi AppTec
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Wuxi Apptec Comparisons
Competitors of WuXi AppTec
WuXi AppTec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eurofins Scientific, Ipsen, ANI Pharmaceuticals, Red Nucleus and Aptar, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Laboratory testing and contract research services are provided globally.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| domain | founded_year | HQ Location |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| domain | founded_year | HQ Location |
Advisory, scientific, and medical communications provided for pharmaceutical industry.
|
|
| domain | founded_year | HQ Location |
Regulatory support, brand differentiation, and prototyping services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Wuxi Apptec
Frequently Asked Questions about WuXi AppTec
When was WuXi AppTec founded?
WuXi AppTec was founded in 2000 and raised its 1st funding round 7 years after it was founded.
Where is WuXi AppTec located?
WuXi AppTec is headquartered in Shanghai, China.
Is WuXi AppTec a funded company?
WuXi AppTec is a funded company, having raised a total of $40M across 5 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $1.5B, raised on Feb 01, 2007.
How many employees does WuXi AppTec have?
As of Dec 31, 2022, the latest employee count at WuXi AppTec is 1,681.
What is the annual revenue of WuXi AppTec?
Annual revenue of WuXi AppTec is $8.27M as on Dec 31, 2023.
What does WuXi AppTec do?
WuXi AppTec is a provider of a suite of CRO and CDMO services for small molecules, biologics, and medical devices. It offers a suite of services for the research, development, and manufacturing of both small molecules and biologics and also caters to medical device development and has operations all over the globe. They provide a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device RD process. The company built its initial capabilities around discovery chemistry and has further enhanced the integrated services with analytical services, bio-analytical services, process research, process development services, API manufacturing services, DMPKADME, discovery biology, pharmacology, formulation, toxicology, genomic services, biologics manufacturing services, antibody, and biological research reagent manufacturing and sales, and most recently clinical research and regulatory services. In 2022, the company recorded annual revenues of 5.84B and a net profit of 1.31B.
Who are the top competitors of WuXi AppTec?
WuXi AppTec's top competitors include ANI Pharmaceuticals, Aptar and CHEPLAPHARM.
How many acquisitions has WuXi AppTec made?
Who are WuXi AppTec's investors?
WuXi AppTec has 5 investors. Key investors include General Atlantic, Warburg Pincus, Eight Roads Ventures, Ping An Bank, and 120 Capital Management.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.